ResearchVEGF
Genentech Biooncology

VEGF and prognosis in colorectal cancer

Evidence from numerous studies and analyses points to vascular endothelial growth factor (VEGF) and angiogenesis as prognostic factors in colorectal cancer. For information on a particular outcome that has been correlated with VEGF expression, click on the links in the table below.

OutcomeStudy Type and SizeSource
Poor survivalClinical study (N=60)

Meta-analysis of 27 studies
Ishigami et al, Br J Cancer, 19985

Des Guetz et al, Br J Cancer, 20064
Increased risk of
relapse
Meta-analysis of 27 studiesDes Guetz et al, Br J Cancer, 20064
MetastasisClinical study (N=133)

Clinical study (N=60)

Clinical study (N=31)
Tanigawa et al, Cancer Res, 199713

Ishigami et al, Br J Cancer, 19985

Kuramochi et al, Clin Cancer Res, 200614
Tumor invasion
and lymph node
involvement
Clinical study (N=72)


Clinical study (N=90)
Ottaiano et al, Clin Cancer Res, 200615

Saad et al, Mod Pathol, 200616


Next section

Survival

View references
for this site section